We previously reported that a typical matrine-type lupine alkaloid, (ϩ)-matrine (1), produced by some Sophora plants (Leguminosae) has antinociceptive properties that are identical to those of pentazocine, which are mediated mainly through activation of k-opioid receptors and partially through m-opioid receptors.
solved in saline or suspended in 0.5% carboxymethyl cellulose sodium salt (CMC). In the control group each mouse was injected with saline or 0.5% CMC in a volume of 10 ml/kg.
Acetic Acid-Induced Abdominal Contraction Assay (Writhing Test) Each mouse was injected i.p. with 0.7% acetic acid in a volume of 10 ml/kg 30 min after administration of the test drugs (10-100 mg/kg). After 10 min the animals were observed for an additional 10 min during which abdominal contractions were counted. The number of contractions in each test period was normalized to the mean number from the control group. The percent antinociception was expressed as: 100ϫ(mean control responsesϪtest responses)/(mean control responses).
Data Analysis All data are expressed as meansϮS.E. The statistical significance of differences between groups was assessed with analysis of variance followed by the Bonferroni-Dunn test. The ED 50 values and 95% confidence intervals for the antinociceptive effects of compounds 3a-c and 4a-c were determined by linear regression techniques.
RESULTS
As shown in Fig. 1 , compounds 3a, 3b, and 3c (doses of 10-100 mg/kg, s.c.) produced dose-dependent inhibition of the writhing response in mice. The ED 50 values (mg with 95% confidence intervals) were 69.7 mg (Ϫ148.7 to 288.1 mg) for 3a, 52.6 mg (Ϫ93.7 to 198.9 mg) for 3b, and 74.5 mg (Ϫ201.0 to 349.9 mg) for 3c, respectively. As shown in Fig.  2 , compounds 4a, 4b, and 4c (doses of 10-100 mg/kg, s.c.) produced dose-dependent inhibition of the writhing response in mice. The ED 50 values were 62.1 mg (Ϫ129.9 to 254.1 mg) for 4a, 55.5 mg (Ϫ42.7 to 153.6 mg) for 4b, and 52.5 mg (Ϫ184.9 to 290.0 mg) for 4c, respectively. As above, all drugs with the amide group produced dose-dependent inhibition of the writhing response in mice.
In contrast, as shown in Figs. 3A and B, the antinociceptive potencies of 5a-c and 6a-c (100 mg/kg) were significantly lower than those of the corresponding amides 3a-c and 4a-c, respectively.
DISCUSSION
These experiments showed that 1-acyl-4-dialkylaminopiperidines 3a-c and 4a-c, which include the amide groups, produce dose-dependent antinociception in mice. The antinociceptive effects of 3a-c and 4a-c were approximately 2.5 times greater than those of 5a-c and 6a-c, respective- ly. These findings indicate that the amide group of (ϩ)-matrine (1) is essential for antinociceptive potency. Development of matrine derivatives with greater potencies may be possible by further improvement of the lipophilicity through an acyl group and a less hindered tertiary amino group, because the antinociceptive potency of compound 3b, which contains pentanoyl and dimethylamino groups, was greater than that of the other synthesized compounds. We obtained information in this study on structure-activity relations, but we failed to identify any compound with an antinociceptive potency greater than (1).
MATERIALS AND METHODS

General
High resolution MS (HR-MS) were measured at 70 eV using a direct inlet system on a JEOL D300 spectrometer. 1 H-(270 MHz) and 13 C-NMR (67.8 MHz) spectra were recorded using tetramethylsilane (TMS) as an internal standard with a JEOL JNM-LA270 spectrometer. Column chromatography was carried out on Silica gel 60 (100-210 mm, Kanto Chemical Co., Inc.), Wako gel C-300 (45-75 mm, Wako Pure Chemical Industries, Ltd.), and Lichrospher Si 60 (40-63 mm, Merck).
1-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)ethanone, 8a
To a solution of the amine 7 (3.00 g, 20.95 mmol), triethylamine (9.40 ml, 62.83 mmol) and dimethylaminopyridine (DMAP) (0.26 g, 2.13 mmol) in CH 2 Cl 2 (20 ml), cooled to 0°C under nitrogen ,was added the acetic anhydride (3.00 ml, 31.74 mmol). The reaction mixture was stirred at 0°C for 1 h. Then 10% NaOH was added, the organic layer was separated, and the aqueous layer was extracted with CH 2 Cl 2 . The organic layer was washed with 10% HCl, dried (Na 2 SO 4 ) and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate) and gave 8a as colorless oil (3.85 g, 99% (1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)phenylmethanone, 8c As described for the preparation of 8a, the amine 7 (1.30 g, 9.08 mmol) was acylated with benzoyl chloride (1.58 ml, 13.59 mmol), DMAP (0.11 g, 0.90 mmol), and triethylamine (3.80 ml, 27.37 mmol) in CH 2 C1 2 (10 ml), and purified by silica gel column chromatography (ethyl 1-Acetylpiperidin-4-one, 9a To a solution of the amide 8a (3.83 g, 20.68 mmol), 5% HCl (10 ml) in MeOH (10 ml) was added and the mixture was stirred at room temperature for 19 h. The reaction mixture was evaporated, and the aqueous layer was extracted with CH 2 Cl 2 . The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. The residue was purified by silica gel column chromatography (ethyl acetate), to give 9a as colorless oil (2.04 g, 70% 1-Pentanoylpiperidin-4-one, 9b As described for the preparation of 9a, the amide 8b (4.51 g, 19.84 mmol) was deprotected with 5% HCl (10 ml) in MeOH (10 ml) for 53 h, and purified by silica gel column chromatography (ethyl ac- 
1-Benzoylpiperidin-4-one, 9c
As described for the preparation of 9a, the amide 8c (2.23 g, 9.02 mmol) was deprotected with 5% HCl (5 ml) in MeOH (5 ml) for 50 h, and purified by silica gel column chromatography ( 1-(4-Dimethylaminopiperidin-1-yl)ethanone, 3a To a solution of the ketone 9a (1.08 g, 7.65 mmol) in EtOH (13 ml) was successively added dimethylamine hydrochloride (1.35 g, 16.55 mmol), 3 Å molecular sieves, and NaBH 3 CN (0.80 g, 12.73 mmol). To the reaction mixture HCl/EtOH was added until pH 6 and stirred for 96 h at room temperature. Then it was evaporated, water (5 ml) and CH 2 Cl 2 (10 ml) were added, the suspension was filtered, and the filtrate was washed with a saturated solution of NaOH and NaCl, dried (Na 2 SO 4 ), and concentrated in vacuo. The residue was purified by silica gel column chromatography (CH 2 Cl 2 /MeOH/ NH 4 OHaq 70 : 9 : 1), to give 3a as colorless oil (0.69 g, 53% 1-(4-Dimethylaminopiperidin-1-yl)pentan-1-one, 3b As described for the preparation of 3a, the ketone 9b (0.66 g, 3.60 mmol) was reductively aminated with dimethylamine hydrochloride (0.73 g, 9.00 mmol), NaBH 3 CN (0.23 g, 3.66 mmol), and purified by silica gel column chromatography (CH 2 (4-Dimethylaminopiperidin-1-yl)phenylmethanone, 3c As described for the preparation of 3a, the ketone 9c (1.96 g, 9.64 mmol) was reductively aminated with dimethylamine hydrochloride (1.96 g, 24.00 mmol), NaBH 3 CN (0.61 g, 9.71 mmol), and purified by silica gel column chromatography (CH 2 Cl 2 /MeOH/NH 4 OHaq 90 : 9 : 1): colorless oil, yield 1.00 g (45%); 1 H-NMR (DMSO-d 6 , 80°C) d: 1.17-1.32 (2H, m), 1.65 (2H, dm, 14.3 Hz), 2.09 (3H, m), 2.24 (1H, dddd, Jϭ10.7, 10.7, 3.8, 3.8 Hz), 2.82 (1H, ddd, Jϭ11.1, 11.1, 2.8 Hz), 3.89 (1H, Br), 7.22-7.37 (5H, aromatic). 1-(4-Dibutylaminopiperidin-1-yl)ethanone, 4a To a solution of the ketone 9a (0.90 g, 6.34 mmol), dibutylamine (0.98 g, 7.58 mmol) and p-toluenesulfonic acid monohydrate (TsOH · H 2 O) (0.12 g, 0.63 mmol) in benzene (10 ml) was added and the mixture was then refluxed with Dean-Stark for 24 h. The reaction mixture was concentrated in vacuo. The residue was dissolved in EtOH (6 ml), NaBH 4 (0.24 g, 6.34 mmol) was slowly added and stirred at room temperature for 1 h. Then it was evaporated, water (5 ml) and CH 2 Cl 2 (20 ml) were added, the suspension was filtered, and the filtrate was washed with a saturated solution of NaOH and NaCl, dried (Na 2 SO 4 ), and concentrated in vacuo. The residue was purified by silica gel column chromatography (CH 2 Cl 2 /MeOH/NH 4 OHaq 90 : 9 : 1), to give 4a as colorless oil (1.37 g, 85%) . 1 (4-Dibutylaminopiperidin-1-yl)phenylmethanone, 4c As described for the preparation of 4a, the ketone 9c (0.87 g, 4.28 mmol) was reductively aminated with dibutylamine (0.67 g, 5.18 mmol), NaBH 4 (4-Dimethylaminopiperidin-1-yl)ethane, 5a To a solution of lithium aluminum hydride (LiAlH 4 ) (0.23 g, 6.06 mmol) in THF (3 ml) was added the solution of 3a (676 mg, 3.97 mmol) in THF (2 ml), and then refluxed under nitrogen atmosphere for 2 h. The reaction mixture was quenched with water, and the solvent was evaporated. The residue was dissolved in CH 2 Cl 2 , washed with saturated K 2 CO 3 and brine, dried over Na 2 SO 4 , and the solvent was evaporated. The residue was purified by silica gel column chromatography (CH 2 Cl 2 /MeOH/NH 4 OHaq 50 : 9 : 1) to give 5a as colorless oil (456 mg, 74% 
